Physician profile
David B Conley
NPI 1437112190
$630,340.82
in general payments reported to CMS, 2019-2025
13 companies · $189K in 2025
The $189K reported for 2025 was more than what 99% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91K · 2020: $20K · 2021: $15K · 2022: $67K · 2023: $110K · 2024: $140K · 2025: $189K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $336K · Travel and Lodging: $47K · Consulting Fee: $44K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $336,197.25 |
| Travel and Lodging | $47,030.21 |
| Consulting Fee | $43,596.00 |
| Food and Beverage | $11,199.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $284,411.32 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $123,632.32 | 2019-2022 | |
| Genzyme Corporation | $121,370.43 | 2023-2025 | |
| Medtronic, INC. | $97,992.30 | 2021-2025 | Propel, Sinuva, Fusion |
| Aerin Medical INC. | $873.46 | 2023-2025 | |
| Stryker Corporation | $705.44 | 2019-2022 | |
| Medtronic USA, INC. | $400.93 | 2019-2020 | |
| Acclarent, INC | $361.27 | 2019-2024 | Trudi Nav Cable |
| Glaxosmithkline, LLC. | $216.47 | 2024 | Nucala |
| Optinose US, INC. | $133.14 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $125.79 | 2025 | Tezspire |
| Xoran Technologies LLC | $80.75 | 2019 | |
| Depuy Synthes Sales INC. | $37.20 | 2024 | Trumatch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Conley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.